Whole-Person Care: The Benefits Are Already There
We do not need to invent new benefits to protect HealthSpan. We need to stop administering the ones we already have on separate tracks, and weave supplemental, behavioral, and pharmacy into a single care journey. The facts say it saves money. The only thing missing is the integration.
By RaeAnn
The HealthSpan piece argued that a health system should preserve function across a whole life and pay only for the services that measurably protect it. A fair reader finishes that argument and asks the obvious question: fine, but with what. What are the actual levers a plan can pull to preserve function, and do we have to build them from scratch. The answer, and it is a genuinely hopeful one, is that we mostly already have them. Medicare Advantage plans already offer behavioral health benefits, medication coverage, transportation, dental, vision, and hearing. The benefits are there. What is missing is that we administer each one on its own track, through its own vendor, measured by its own siloed metric, as if a member’s mental health had nothing to do with whether she takes her medication, and her ride to the doctor had nothing to do with whether she ends up in the emergency room. This piece is about what happens when you stop doing that.
I want to keep this one grounded in facts rather than theory, because the facts are strong enough to carry the argument on their own. When supplemental benefits, behavioral health, and pharmacy are woven into the care journey rather than bolted on beside it, four things happen at once: care gets more accessible, more affordable, more preventive, and better aligned to the member’s actual health. And every one of those four, the research shows, lowers the total cost of care. This is the rare case where the humane thing and the financially disciplined thing are the same thing.
We are not short on benefits. We are short on integration. The dental plan, the pharmacy, the ride, and the therapist are all already in the room. They just never talk to each other.
The Facts, Before the Argument
Here is the evidence base condensed, and then I will walk each lever in turn. Read the right-hand column as the answer to the CFO’s only real question: does integrating this actually bend cost.
|
Lever |
What the evidence shows |
The cost signal |
|
Behavioral integration |
Collaborative care: 54% less ER use, 49% less inpatient psychiatric care |
~$6 saved per $1 spent; >$3,000/patient/yr (IMPACT) |
|
Medication adherence |
Adherent patients have fewer admissions and ER visits |
23% lower total cost (CHF); up to 13:1 in older HTN patients |
|
Transportation |
Roughly one-third fewer missed appointments |
~4M Americans miss/delay care yearly for lack of a ride |
|
Dental / oral health |
Periodontal care lowers diabetes complications |
12–14% lower total costs; up to $14.5B Medicare potential |
|
Vision & hearing |
Correcting sensory loss cuts falls, isolation, cognitive decline |
Untreated loss drives avoidable acute and long-term cost |
Better Mental Wellness, Better Adherence, Lower Cost
Start with behavioral health, because it sits underneath almost everything else. Untreated depression and anxiety are not separate from a member’s diabetes or heart failure; they are frequently the reason those conditions spiral, because a person in a depressive episode does not take medications on schedule, does not keep appointments, and does not follow a care plan. Integrating behavioral health into primary care through the collaborative care model, rather than referring it out to a disconnected specialist, is one of the most rigorously validated interventions in all of medicine, backed by more than eighty randomized trials.1 The landmark IMPACT trial of collaborative care for depression in older adults saved more than $3,000 per patient in total healthcare costs within a year, against an intervention cost of roughly fifty dollars.2 Across studies the model returns on the order of six dollars for every dollar spent, and members receiving it are 54 percent less likely to visit the emergency room and 49 percent less likely to need inpatient psychiatric care.1
The mechanism is exactly the whole-person logic this series keeps returning to. Treat the depression and the diabetes together and each treatment makes the other work better: a landmark integrated depression-and-diabetes program produced sustained improvements in blood sugar, blood pressure, and cholesterol, with the intervention cost offset by medical savings.3 Better mental wellness is not a soft benefit sitting off to the side of the medical budget. It is the thing that makes the medical budget work.
Better Medication Adherence, Less Costly Care
Pharmacy is the second lever, and it is the one with the cleanest arithmetic. When people actually take the medications they are prescribed, they are hospitalized less and visit the emergency room less, and the medical savings dwarf the added drug spend. In congestive heart failure, adherent patients ran total healthcare costs 23 percent lower than non-adherent patients.4 The benefit compounds with age: benefit-to-cost ratios run from roughly two to one for younger adults on cholesterol medication to better than thirteen to one for older adults with hypertension.5 Run the other direction and the waste is staggering. Medication non-adherence is estimated to cause around 10 percent of all hospitalizations and to cost the health system somewhere between one hundred and nearly three hundred billion dollars a year, with roughly 13.7 billion dollars in potential savings in Medicare fee-for-service spending alone.6
The integration point is that adherence is not primarily a pharmacy problem. It is a whole-person problem. People miss doses because of cost, because of side effects no one is managing, because of the untreated depression from the previous section, because they cannot get to the pharmacy, or simply because no one is coordinating a medication list scattered across several prescribers. Every one of those causes is addressable, and none of them is solved by the pharmacy operating in isolation.
A Ride to the Doctor, or a Bill from the Emergency Room
Transportation is the lever that looks smallest and pays back most visibly. Roughly four million Americans miss or delay medical care every year simply because they lack a way to get there.7 A missed primary care visit is not a saving; it is a deferral, and deferred care has a way of returning as an emergency. Providing non-emergency medical transportation reduces missed appointments by roughly a third, according to a meta-analysis of the intervention.8 The logic a CFO can follow in one line: a ten or twenty dollar ride to a primary care visit is a great deal cheaper than the emergency room visit that the missed appointment eventually produces. Medicare Advantage plans already cover these rides. The question is whether the transportation benefit is connected to the care plan, so that the ride is offered before the missed appointment, or whether it sits in a vendor silo waiting to be requested by a member who may not know it exists.
A twenty-dollar ride to the primary care doctor is the cheapest emergency room diversion in all of healthcare. We already pay for the ride. We just do not connect it to the visit.
Dental, Vision, and Hearing: The Benefits We Treat as Cosmetic
The supplemental benefits that plans most often treat as enrollment sweeteners, dental, vision, and hearing, turn out to be genuine medical-cost levers when they are integrated into the clinical picture rather than administered as perks. The oral health case is the best documented. Periodontal disease and diabetes have a well-established bidirectional relationship, and treating the gum disease measurably lowers the medical cost of the diabetes: studies of commercial and Medicaid claims found total healthcare costs 12 to 14 percent lower for diabetic patients who received periodontal treatment.9 One analysis estimated that adding comprehensive periodontal treatment to Medicare could save up to 14.5 billion dollars a year for patients with diabetes alone.10 Untreated oral disease does not stay in the mouth; it shows up as emergency room visits and as worse control of the systemic conditions that drive the largest costs.
Vision and hearing follow the same pattern. Uncorrected vision loss and diabetic retinopathy track with falls, with cardiovascular disease, and with cognitive decline. Untreated hearing loss is now recognized as one of the most significant modifiable risk factors for dementia, and it drives the social isolation that this series has already named as a mortality-level variable. A member who cannot see well falls and fractures a hip; a member who cannot hear withdraws, declines, and loses function. These are not cosmetic benefits. They are HealthSpan benefits, and every one of them, delivered well, protects the PreservationSpan and lowers the cost of the acute events that poor sensory health produces.
The Whole Is Cheaper Than the Sum of the Silos
Put the levers together and a single pattern emerges. Better mental wellness improves medication adherence. Better adherence prevents the complications that drive hospitalization. A ride to the primary care visit prevents the emergency room trip. Dental care lowers the cost of diabetes. Corrected vision and hearing prevent the fall and the isolation-driven decline. None of these is a new benefit. Each already exists inside the typical Medicare Advantage plan. The entire opportunity lies in weaving them into one care journey organized around the member, so that the ride is connected to the visit, the behavioral health is connected to the chronic disease, and the pharmacy is connected to the person rather than the prescription.
This is the operational meaning of whole-person care, and it maps directly onto the framework this series has built. Accessibility, affordability, prevention, and alignment are not four separate initiatives. They are what integration produces, all at once, and together they lower the cost of care while extending the years a member stays whole, capable, and progressing. Measured against the PreservationSpan, integration is not a cost. It is the highest-return investment a plan can make in the thing it is ultimately paid to protect.
WHAT INTEGRATION ASKS OF A PLAN
Nothing here requires inventing a benefit or adding a line of business. It requires connecting benefits that already exist: a shared view of the member across behavioral, pharmacy, transportation, and supplemental, and a care journey that offers the right one at the right moment rather than waiting for the member to find it.
The near-term return is fewer avoidable admissions, emergency visits, and readmissions. The durable return is a population that holds function longer, which is the compounding asset. Both are measurable, and both point the same direction.
I have deliberately left one thing out of this piece: exactly how a plan writes integration into a contract and gets paid for it. That mechanism, the value-based structure that funds whole-person care and holds it accountable, is its own detailed piece of work, and it is where this series turns next.
That is the next piece in this series.
Sources
Cost and outcome figures are drawn from peer-reviewed studies, randomized trials, and claims analyses. Where a range appears, it reflects variation across the underlying studies.
- Collaborative Care Model evidence base: 80+ randomized trials; members ~54% less likely to use the ER and ~49% less likely to need inpatient psychiatric care; ~$6 returned per $1 spent. Psychiatry.org / AJMC / integrated-care reviews. https://www.psychiatry.org/psychiatrists/practice/professional-interests/integrated-care/learn
- IMPACT trial (Unützer et al.): collaborative care for late-life depression saved >$3,000 per patient in total healthcare costs over ~1 year against ~$50 intervention cost. https://cmsatoday.com/2024/07/23/collaborative-care-revisited-addressing-mental-health-through-primary-care-case-management/
- INDEPENDENT / TEAM care-style integrated depression-and-diabetes trials: sustained improvements in HbA1c, systolic BP, and LDL, with intervention costs offset by medical savings. https://cdn.clinicaltrials.gov/large-docs/11/NCT02022111/Prot_SAP_001.pdf
- Medicaid CHF cohort: adherent patients had fewer hospitalizations and ER visits and ~23% lower total healthcare costs than non-adherent patients (Pharmacy Times review of adherence literature). https://www.pharmacytimes.com/view/increased-medication-adherence-reduces-health-care-costs
- Benefit-to-cost ratios of adherence rise with age: ~2:1 for younger adults with dyslipidemia to >13:1 for older adults with hypertension (adherence economics literature). https://www.mc-rx.com/medication-adherence-lowers-healthcare-costs-and-improves-patients-outcomes
- Non-adherence estimated to cause ~10% of hospitalizations and cost ~$100–290B/year; ~$13.7B potential savings in Medicare fee-for-service alone (AJMC; adherence cost literature). https://www.ajmc.com/view/association-of-co-pay-elimination-with-medication-adherence-and-total-cost
- Roughly 4 million Americans miss or delay medical care each year due to lack of transportation. https://www.mtm-inc.net/healthcare/nemt/
- Systematic review and meta-analysis of non-emergency transportation interventions: pooled missed-appointment ratio ~0.63, i.e., roughly one-third fewer missed appointments favoring the intervention. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026972/
- Periodontal treatment associated with ~12–14% lower total healthcare costs for patients with diabetes in Medicaid and commercial claims (JADA; MarketScan analyses). https://pubmed.ncbi.nlm.nih.gov/36841690/
- Estimate that including comprehensive periodontal treatment in Medicare could save up to ~$14.5B annually for patients with diabetes (CareQuest Institute). https://www.carequest.org/resource-library/periodontal-treatment-associated-decreased-diabetes-related-treatment-costs